THE MEDIDATA EXPERIENCES
More Than a Strategy.
The Only Viable Operating Model.
Clinical trials have crossed a structural threshold. Protocols are more complex. Data volume has exploded. Yet many organizations still operate across disconnected
systems stitched together by reconciliation teams.
Connecting Experiences—across Patient, Data, and Study—
is the only operating model capable of sustaining
modern clinical research at scale.
Experiences
as One Operating System
Sponsors and CROs aren’t asking for more point solutions. They demand end-to-end workflows, reduced vendor complexity,
fewer integration points, and measurable acceleration.
Connecting Experiences strengthens the entire trial by creating a continuous, intelligently unified system where data, workflows, and decisions inform and reinforce one another in real time.
PROVEN GLOBAL PLATFORM
of all FDA novel drug approvals in 2025
TRUSTED WORLDWIDE
customers and trial sites in 140+ countries
EMBEDDED TRAINED AI
data points annually
DECADES OF LONGITUDINAL DATA
trials used Medidata technology
Patient Experience
Engagement that drives trial ROI
Drive stronger recruitment, faster enrollment, deeper engagement, better adherence, and sustained retention—during and beyond the trial.
Empower patients and sites with a unified platform that eases trial burden and streamlines workflows.
Data Experience
Data that learns. AI that acts.
Data increases dramatically across the trial lifecycle.
Architect, govern, and unlock your data for
integrity, visibility, and insights at all times.
Simplify data workflows and improve data quality with intelligent automation from study build to database lock.
Study Experience
Predict outcomes. Accelerate performance.
Move from design to execution with full visibility.
Accelerate trial planning and delivery using predictive analytics and embedded AI to anticipate risk and act early.
Featured Resource
Beyond the Code: Transforming Clinical Trial Experiences
In a series produced by BBC StoryWorks, Medidata leaders explore how AI and machine learning are transforming trials.